-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Yahong Pharmaceutical announced that it has reached a strategic partnership with Sinopharm Holdings.
The two parties will jointly promote the commercialization, logistics and supply chain services of Yahong Pharmaceutical's innovative products
.
The first cooperative product is Hexvix®, a diagnostic drug for bladder cancer, which is also a further deepening of cooperation between the two parties following the Boao Lecheng Pilot Zone project
Yahong Medicine focuses on the field of genitourinary system tumors and other major diseases, aiming to provide patients with a superior product portfolio from disease diagnosis to treatment, and is determined to create the best integrated diagnosis and treatment solution
.
Hikvision® is currently the only approved imaging agent in the world to assist in the diagnosis or surgery of bladder cancer.
Mr.
Liu Yong, President of Sinopharm Group, said: “We are very happy to cooperate with a global innovative company like Yahong Pharma
.
Sinopharm Group will rely on its comprehensive network layout, strong channel management capabilities, and professional marketing team and services to enable innovation.
Dr.
Pan Ke, founder and CEO of Yahong Pharmaceutical, said: “Sinopharm is a leading company in medical and health service providers
.
With the advantages of Sinopharm’s brand, channels and network coverage, we are very much looking forward to allowing the majority of Chinese patients to use the image as soon as possible.
